SCHEMBL5765616

SCHEMBL5765616

CNc1nc(OC)c(C(N)=O)c(OC)n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.49
ALDH1A1 P00352 1/20 0.37
SQOR Q9Y6N5 1/20 0.35
CDC7 O00311 1/20 0.34
CCNE1 P24864 1/20 0.34
CDK2 P24941 1/20 0.34
DBF4 Q9UBU7 1/20 0.34
KMT2A Q03164 1/20 0.33
NNMT P40261 2/20 0.33
HSD17B10 Q99714 1/20 0.32
KDM4E B2RXH2 2/20 0.32
CTDSP1 Q9GZU7 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.32
MAPK1 P28482 1/20 0.32
LRRK2 Q5S007 2/20 0.32
BRAF P15056 1/20 0.32
PDE4A P27815 1/20 0.32
PDE4B Q07343 1/20 0.32
PDE4C Q08493 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10271733 0.79 POLB (0.45) POLB
SCHEMBL5765825 0.78 POLB (0.53) POLBALDH1A1SQORCDC7CCNE1
SCHEMBL6639435 0.76 POLB (0.51) POLBSQORCDC7CCNE1CDK2
SCHEMBL5765632 0.75 MAPK8 (0.47) POLBKMT2AKDM4EGAANPSR1
SCHEMBL9622945 0.74 ITK (0.44) NNMTLRRK2
SCHEMBL5765353 0.73 POLB (0.39) POLBALDH1A1SQORKMT2APDE4A
SCHEMBL5765619 0.73 ALDH1A1 (0.35) ALDH1A1CDK2MAPK1PDE4A
SCHEMBL5692690 0.70 NNMT (0.32) POLBCDC7CCNE1CDK2DBF4
SCHEMBL16583329 0.69 POLB (0.49) POLBSQORCDC7CCNE1CDK2
SCHEMBL14395834 0.69 ALDH1A1 (0.31) ALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1334972-B1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (GnRH) PFIZER (US) 2006-04-19 EP disclosed
US-6833372-B2 A hormone inhibitors of gonadotropin releasing hormone, an antigonadotropins, new drug compound contains a furanyl 2-carboxylic acid -(2,4-dimethoxy-pyrimidin-5-yl)-amide groups PFIZER, INC. 2004-12-21 US disclosed
US-20040053951-A1 Non-peptide GnRH agents, pharmaceutical compositions, and methods for their use PFIZER INC. 2004-03-18 US disclosed
EP-1334972-A1 Non-peptide compounds affecting the action of gonadotropin-releasing hormone (GnRH) PFIZER INC. (US) 2003-08-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040053951-A1 Non-peptide GnRH agents, pharmaceutical compositions, and methods for their use GNRHR, LHCGR, FSHR POLB 3980/4885ALDH1A1 4860/4885SQOR 4625/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.